중환자실 임상약사의 약물처방 검토 시 필요한 필수점검 항목 개발
Development of an Evidence-based Essential Checklist for the Critical Care Pharmacist
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background and purpose : Clinical pharmacists are core members of a multidisciplinary team in critical care, playing a pivotal role in improving patient treatment. The responsibility of pharmacists for pharmacotherapeutic outcomes in South Korea has increased over the years. However, different interventional approaches or points of view in regard to patient medication exist among pharmacists, especially new team members. The purpose of this study was to set up principles of medication interventions, to develop an evidence-based checklist to minimize the difference of intervention levels, and to standardize tasks in interventions provided by pharmacists. Methods : After a comprehensive review of the literature, guidelines and protocols, the relevant items were identified. They were then structured in the form of a checklist. The consistency of the checklist was checked by a group of pharmacists involved in critical care. Cronbach’s alpha, a measure of internal consistency, was used to validate the checklist. Pharmacists’satisfaction with the checklist was assessed using Likert scales as a questionnaire survey. Results : We established an evidence-based checklist composed of seven categories for use in pharmaceutical interventions in critical care. A total of 69 pharmacists completed a questionnaire surveying satisfaction with the checklist. Consistency between two groups of pharmacists was 99.3 percent. The reliability of the checklist was Cronbach’s alpha 0.899, which validated the checklist. There was high satisfaction (4.32 on the Likert scale) with the checklist among pharmacists. Conclusions : The checklist may provide a useful tool for clinical pharmacists to conduct a highly-specialized critical care pharmaceutical intervention with evidence-based reliability.
Abstract
Background and purpose : Clinical pharmacists are core members of a multidisciplinary team in critical care, playing a pivotal role in improving patient treatment. The responsibility of pharmacists for pharmacotherapeutic outcomes in South Korea has increased over the years. However, different interventional approaches or points of view in regard to patient medication exist among pharmacists, especially new team members. The purpose of this study was to set up principles of medication interventions, to develop an evidence-based checklist to minimize the difference of intervention levels, and to standardize tasks in interventions provided by pharmacists. Methods : After a comprehensive review of the literature, guidelines and protocols, the relevant items were identified. They were then structured in the form of a checklist. The consistency of the checklist was checked by a group of pharmacists involved in critical care. Cronbach’s alpha, a measure of internal consistency, was used to validate the checklist. Pharmacists’satisfaction with the checklist was assessed using Likert scales as a questionnaire survey. Results : We established an evidence-based checklist composed of seven categories for use in pharmaceutical interventions in critical care. A total of 69 pharmacists completed a questionnaire surveying satisfaction with the checklist. Consistency between two groups of pharmacists was 99.3 percent. The reliability of the checklist was Cronbach’s alpha 0.899, which validated the checklist. There was high satisfaction (4.32 on the Likert scale) with the checklist among pharmacists. Conclusions : The checklist may provide a useful tool for clinical pharmacists to conduct a highly-specialized critical care pharmaceutical intervention with evidence-based reliability.
참고문헌 (70)
- Rudis MI, "Position paper on critical care pharmacy services", Crit Care Med, 28(11), pp.3746~3750 (2000)
- Allenet B, "Validation of an instrument for the documentation of clinical pharmacists' interventions", Pharm World Sci, 28(4), pp.181~188 (2006)
- Ellis SL, "Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers", Pharmacotherapy, 20(4), pp.429~435 (2000)
- 정정원, "외과계 중환자실 약사의 처방중재효과 평가", 병원약사회지, 31(4), pp.908~918 (2014), 한국병원약사회[DOI]
- Bond CA, "Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals : summary and recommendations for clinical pharmacy services and staffing", Pharmacotherapy, 21(2), pp.129~141 (2001)
- Kane SL, "The impact of critical care pharmacists on enhancing patient outcomes", Intensive Care Med, 29(5), pp.691~698 (2003)
- "Development of clinical pharmacy services for intensive care units in Korea" (2014)[URL]
- Preslaski CR, "Pharmacist contributions as members of the multidisciplinary ICU team", Chest, 144(5), pp.1687~1695 (2013)
- Vincent JL, "Give your patient a fast hug(at last) once a day", Crit Care Med, 33(6), pp.1225~1229 (2005)
- Masson S, "Validity evidence for FASTHUG-MAIDENS, a mnemonic for identifying drug-related problems in the intensive care unit", Can J Hosp Pharm, 66(3), pp.157~162 (2013)
- Barnes BJ, "Drug-induced arrhythmias", Crit Care Med, 38(6suppl), pp.S188~S197 (2010)
- Greinacher A., "Thrombocytopenia in the intensive care unit patient", Hematology Am Soc Hematol Educ Progr, 2010, pp.135~143 (2010)
- Crowther MA, "Thrombocytopenia in medical-surgical critically ill patients : prevalence, incidence, and risk factors", J Crit Care, 20(4), pp.348~353 (2005)
- Goodman D, "Update on cardiac arrhythmias in the ICU", Curr Opin Crit Care, 14(5), pp.549~554 (2008)
- Drug-Induced Complications in the Critically Ill Patient. : A Guide for Recognition and Treatment, "Papadopoulos J", Society of Critical Care Medicine, 13~83 (2012)
- Kaufman DW, "Drugs in the aetiology of agranulocytosis and aplastic anaemia", Eur J Haematol Suppl, 60, pp.23~30 (1996)
- Kenney C, "Drug-induced thrombocytopenia", Arch Pathol Lab Med, 133(2), pp.309~314 (2009)
- Medina P, "Drug-associated blood dyscrasias", Adv Drug React Bull, 210, pp.803~806 (2001)
- Pontikoglou C, "Idiosyncratic drug-induced agranulocytosis : the paradigm of deferiprone", Hemoglobin, 34(3), pp.291~304 (2010)
- Sanoski CA, "Pharmacotherapy: A Pathophysiologic Approach", pp.279~314 (2008), Mcgraw-Hill Companies, Inc
- Wilson S., "Drug induced diseases. Prevention, detection and management", pp.644~685 (2010), American Society of Health-System Pharmacists
- Vincent JL, "International study of the prevalence and outcomes of infection in intensive care units", JAMA, 302(21), pp.2323~2329 (2009)
- 김성민, "항생제의 길잡이", pp.11~22 (2016), 군자출판사
- 백경란, "중환자의학", pp.419~425 (2016), 군자출판사
- Alhazzani W. Alenezi F, "Proton pump inhibitors versus histamine 2receptor antagonists for stress ulcer pro-phylaxis in critically ill patients : a systematic review and meta-analysis", Crit Care Med, 41(3), pp.693~705 (2013)
- Barkun AN, "Costeffectiveness analysis : stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists", Value Health, 16(1), pp.14~22 (2013)
- Barkun AN, "Proton pump inhibitors vs. histamine 2receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis", Am J Gastroenterol, 107(4), pp.507~520 (2012)
- Bateman BT, "Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study", BMJ, 347, pp.f5416~ (2013)
- Cook D, "A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group", N Engl J Med, 338(12), pp.791~797 (1998)
- Cook D, "Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group", Crit Care Med, 27(12), pp.2812~2817 (1999)
- Cook DJ, "Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group", N Engl J Med, 330(6), pp.377~381 (1994)
- Cook DJ, "Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses", JAMA, 275(4), pp.308~314 (1996)
- Cook DJ, "Histamine-2-receptor antagonists and antacids in the critically ill population:stress ulceration versus nosocomial pneumonia", Infect Control Hosp Epidemiol, 15(7), pp.437~442 (1994)
- Atiq F, "A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins(LMWHs)in patients with renal insufficiency", Eur J Clin Pharmacol, 71(8), pp.921~929 (2015)
- Attia J, "Deep vein thrombosis and its prevention in critically ill adults", Arch Intern Med, 161(10), pp.1268~1279 (2001)
- Boyce SW, "A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis : PREVENT-HIT study", Am J Ther, 18(1), pp.14~22 (2011)
- The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, "Dalteparin versus unfractionated heparin in critically ill patients", N Engl J Med, 364(14), pp.1305~1314 (2011)
- Decousus H, "Factors at admission associated with bleeding risk in medical patients : findings from the IMPROVE investigators", Chest, 139(1), pp.69~79 (2011)
- Falck-Ytter Y, "Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guide-lines", Chest, 141(2suppl), pp.e278S~e325S (2012)
- Gangireddy C, "Risk factors and clinical impact of postoperative symptomatic venous thromboembolism", J Vasc Surg, 45(2), pp.335~342 (2007)
- Geerts W, "Venous thromboembolism and its prevention in critical care", J Crit Care, 17(2), pp.95~104 (2002)
- Goldhaber SZ, "Pulmonary embolism and deep vein thrombosis", Lancet, 379(9828), pp.1835~1846 (2012)
- Bauer L., "Clinical pharmacokinetics. Handbook. International", pp.3~456 (2006), The McGraw-Hill
- Schentag J, "Applied pharmacokinetics & pharmacodynamics. Principles of therapeutic drug monitoring", pp.285~327 (2006), Lippincott Williams & Wilkin
- Murphy J., "Clinical pharmacokinetics", pp.1~350 (2012), American Society of Health-System Pharmacists
- Winter M., "Basic clinical pharmacokinetics", pp.134~510 (2010), Lippincott Williams &Wilkins, a Wolters Kluwer business
- Clinical Practice Guidelines for the Management of Pain, "Agitation, and Delirium in Adult Patients in the Intensive Care Unit", Crit Care Med, 41(1), pp.263~306 (2013)
- Devlin JW, "Efficacy and safety of quetiapine in critically ill patients with delirium : a prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study", Crit Care Med, 38(2), pp.419~427 (2010)
- Girard TD, "Delirium in the intensive care unit", Crit Care, 12(Suppl 3), pp.S3~ (2008)
- Hogarth DK, "Management of sedation in mechanically ventilated patients", Curr Opin Crit Care, 10(1), pp.543~547 (2004)
- "ICU Delirium and Cognitive Impairment Study Group"[URL]
- Kam PC, "Propofol infusion syndrome", Anaesthesia, 62(7), pp.690~701 (2007)
- Milton J., "Marino's the ICU Book", pp.901~921 (2014), Wolters Kluwer
- Payen JF, "Current practices in sedation and analgesia for mechanically ventilated critically ill patients : A prospective multicenter patient-based study", Anesthesiology, 106(4), pp.687~695 (2007)
- Anker SD, "ESPEN Guidelines on Parenteral Nutrition : on cardiology and pneumology", Clin Nutr, 28(4), pp.455~460 (2009)
- Cano NJ, "ESPEN Guidelines on Parenteral Nutrition : adult renal failure", Clin Nutr, 28(4), pp.401~414 (2009)
- McClave SA, "Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)", JPEN J Parenter Enteral Nutr, 40(2), pp.159~211 (2016)
- van Zanten AR., "Nutritional support and refeeding syndrome in critical illness", Lancet Respir Med, 3(12), pp.904~905 (2015)
- Plauth M, "ESPEN Guidelines on Parenteral Nutrition : hepatology", Clin Nutr, 28(4), pp.436~444 (2009)
- Crook MA., "Refeeding syndrome: Problems with definition and management", Nutrition, 30(11-12), pp.1448~1455 (2014)
- Walmsley R., "Refeeding syndrome: Screening, incidence, and treatment during parenteral nutrition", J Gastroenterol Hepatol, 28(Suppl 4), pp.113~117 (2013)
- Mehanna H, "Refeeding syndrome : what it is, and how to prevent and treat it", BMJ, 336(7659), pp.1495~1498 (2008)
- Hales B, "The checklist--a tool for error management and performance improvement", J Crit Care, 21(3), pp.231~235 (2006)
- Pronovost P, "An intervention to decrease catheterrelated bloodstream infections in the ICU", N Engl J Med, 355(26), pp.2725~2732 (2006)
- Dobkin E, "Checkoffs play key role in SICU improvement", Healthcare Bencmarks Qual Improv, 10(10), pp.113~115 (2003)
- Haynes A, "A surgical safety checklist to reduce morbidity and mortality in a global population", N Engl J Med, 360(5), pp.491~499 (2009)
- 손유민, "중환자약료", J. Kor. Soc. Health-Syst. Pharm, 33(2), pp.172~183 (2016)
- Jiang SP, "Effectiveness of pharmaceutical care in an intensive care unit from China. A pre-and post-intervention study", Saudi Med J, 33(7), pp.756~762 (2012)
- Klopotowska JE, "On-ward participation of a hospital pharmacist in d Dutch intensive care reduces prescribing errors and related patient harm:an intervention study", Crit Care, 14(5), pp.R174~ (2010)
- Jiang SP, "Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit", Scand J Infect Dis, 45(12), pp.891~899 (2013)